UTHRUnited Therapeutics Corporation

$24B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.3B+15.4% YoY

Gross Profit

$1.2B90.2% margin

Operating Income

$539M41.8% margin

Net Income

$340M26.4% margin

EPS (Diluted)

$6.28

Cash Flow

Operating Cash Flow

$355M

Free Cash Flow

$308M

Stock-Based Comp.

$190M

Balance Sheet

Total Assets

$1.9B

Total Liabilities

$619M

Stockholders' Equity

$1.3B

Cash & Equivalents

$398M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.3B	$1.1B	+15.4%
Gross Profit	$1.2B	$986M	+17.9%
Operating Income	$539M	$292M	+84.2%
Net Income	$340M	$175M	+94.8%

UTHR FY 2014 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena